Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.12
-2.88 (-1.37%)
AAPL  262.68
-1.50 (-0.57%)
AMD  193.51
-6.70 (-3.35%)
BAC  49.63
-0.20 (-0.39%)
GOOG  304.81
-6.62 (-2.13%)
META  648.50
+0.32 (0.05%)
MSFT  398.24
+5.50 (1.40%)
NVDA  179.34
+2.15 (1.21%)
ORCL  144.71
-0.69 (-0.48%)
TSLA  396.09
-6.42 (-1.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.